UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

Journal of clinical oncology, 2008-03, Vol.26 (9), p.1435-1442

2008

Volltextzugriff (PDF)

Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation

Haematologica (Roma), 2013-05, Vol.98 (5), p.765-770

2013

Volltextzugriff (PDF)

Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS)

BMJ open, 2016-01, Vol.6 (1), p.e009558-e009558

2016

Volltextzugriff (PDF)

Prognostic Impact of Minimal Residual Disease in CBFB-MYH11-Positive Acute Myeloid Leukemia

Journal of clinical oncology, 2010-08, Vol.28 (23), p.3724-3729

2010

Volltextzugriff (PDF)

Phase I/II Study of Sequential Dose-Intensified Ifosfamide, Cisplatin, and Etoposide Plus Paclitaxel As Induction Chemotherapy for Poor Prognosis Germ Cell Tumors by the German Testicular Cancer Study Group

Journal of clinical oncology, 2007-12, Vol.25 (36), p.5742-5747

2007

Volltextzugriff (PDF)

Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap study

Journal of geriatric oncology, 2023-11, Vol.14 (8), p.101638-101638, Article 101638

2023

Volltextzugriff (PDF)

Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic 18F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group

Cancers, 2019-06, Vol.11 (6), p.790

2019

Volltextzugriff (PDF)

Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM)

Bone marrow transplantation (Basingstoke), 2003-06, Vol.31 (11), p.973-979

2003

Volltextzugriff (PDF)

Monotherapy with pixantrone in histologically confirmed relapsed or refractory aggressive B‐cell non‐Hodgkin lymphoma: post‐hoc analyses from a phase III trial

British journal of haematology, 2016-09, Vol.174 (5), p.692-699

2016

Volltextzugriff (PDF)

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

The New England journal of medicine, 2020-12, Vol.383 (26), p.2526-2537

2020

Volltextzugriff (PDF)

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study

The lancet oncology, 2015-09, Vol.16 (9), p.1025-1036

2015

Volltextzugriff (PDF)

Impact of RAS status and prior targeted therapy on the activity of aflibercept plus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in daily practice. Final results of the QoLiTrap prospective non-interventional study

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e15570-e15570

2021

Volltextzugriff (PDF)

Long Term Follow-Up Shows No Clinical Benefit for CD34+ Selection of Autologous Transplants Following Myeloablative Therapy in Patients with Newly Diagnosed Myeloma : An EBMT Phase III Randomized Study

BLOOD, 2004-11, Vol.104 (11), p.921-921

2004

Volltextzugriff (PDF)

In vitro and in vivo purging of B lymphoma cells from stem-cell products using anti-CD20 Abs

Cytotherapy (Oxford, England), 2000-06, Vol.2 (6), p.445-453

Derigs, H.G.

2000

Volltextzugriff (PDF)

Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic 18 F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group

Cancers, 2019-06, Vol.11 (6)

2019

Volltextzugriff (PDF)

Prognostic Impact of Minimal Residual Disease inCBFB-MYH11–Positive Acute Myeloid Leukemia

Journal of clinical oncology, 2010-08, Vol.28 (23), p.3724

2010

Volltextzugriff (PDF)

Myeloablative intensified conditioning regimen with in vivo T-cell depletion

Bone marrow transplantation (Basingstoke), 2003-06, Vol.31 (11), p.973

2003

Volltextzugriff (PDF)

Primary myelodysplastic syndromes : analysis of prognostic factors in 235 patients and proposals for an improved scoring system

Leukemia, 1992, Vol.6 (1), p.52-59

1992

Volltextzugriff (PDF)

LIF mRNA expression in transcriptionally regulated in murine bone marrow stromal cells

Leukemia, 1993-04, Vol.7 (4), p.630-634

1993

Volltextzugriff (PDF)

Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin's lymphoma

Annals of hematology, 2006-11, Vol.85 (11), p.769-779

2006

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Humans
(19)
Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Male
(16)
Middle Aged
(16)
Female
(15)
Adult
(14)
Aged
(11)
Hematology
(11)
Disease-Free Survival
(8)
Oncology
(8)
Follow-Up Studies
(7)
Prognosis
(7)
Treatment Outcome
(7)
Adolescent
(6)
Aged, 80 And Over
(6)
Biological And Medical Sciences
(6)
Survival Rate
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Medical Sciences
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(5)
Journal Of Clinical Oncology
(5)
Bone Marrow Transplantation
(2)
Cancers
(2)
Haematologica
(2)
Leukemia
(2)
Annals Of Hematology
(1)
Biology Of Blood And Marrow Transplantation
(1)
Bmj Open
(1)
British Journal Of Haematology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study

Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation

Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD

Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS)

Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients

Prognostic Impact of Minimal Residual Disease in CBFB-MYH11-Positive Acute Myeloid Leukemia

Phase I/II Study of Sequential Dose-Intensified Ifosfamide, Cisplatin, and Etoposide Plus Paclitaxel As Induction Chemotherapy for Poor Prognosis Germ Cell Tumors by the German Testicular Cancer Study Group

Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap study

Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic 18F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group

Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM)

Monotherapy with pixantrone in histologically confirmed relapsed or refractory aggressive B‐cell non‐Hodgkin lymphoma: post‐hoc analyses from a phase III trial

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG)

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study

Impact of RAS status and prior targeted therapy on the activity of aflibercept plus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in daily practice. Final results of the QoLiTrap prospective non-interventional study

Long Term Follow-Up Shows No Clinical Benefit for CD34+ Selection of Autologous Transplants Following Myeloablative Therapy in Patients with Newly Diagnosed Myeloma : An EBMT Phase III Randomized Study

In vitro and in vivo purging of B lymphoma cells from stem-cell products using anti-CD20 Abs

Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic 18 F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group

Prognostic Impact of Minimal Residual Disease inCBFB-MYH11–Positive Acute Myeloid Leukemia

Myeloablative intensified conditioning regimen with in vivo T-cell depletion

Primary myelodysplastic syndromes : analysis of prognostic factors in 235 patients and proposals for an improved scoring system

LIF mRNA expression in transcriptionally regulated in murine bone marrow stromal cells

Prospective Phase III Trial Of Valproic Acid (VPA) In Combination With All-Trans Retinoic Acid (ATRA) and Intensive Induction Therapy For AML In Older Patients: Final and Molecular Subset Analyses Of The AMLSG 06-04 Study

Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin's lymphoma

Suchergebnisse filtern